People

Ginnie (Hsiu-Chiung) Yang
Ginnie Yang joined Wave in 2023 to lead translational medicine. Her drug-discovery experience spans metabolic, hepatic, central nervous system and cardiovascular diseases and multiple therapeutic modalities. She previously held research and translational leadership roles at Bayer, Novo Nordisk, AstraZeneca and Eli Lilly. She earned a medical biochemistry PhD at Ohio State and undertook postdoctoral research at UC San Diego.
Roles
Wave Life Sciences
CurrentSenior Vice President, Translational Medicine